118th Congress · HOUSE BILLBILL

H.R. 1199Facilitating Innovative Nuclear Diagnostics Act of 2023

To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceuticals under the Medicare hospital outpatient prospective payment system.

Health
Introduced Feb 27, 2023
Last action May 16, 2024
Pipeline · Bill → Law
Step 1
Introduced
Feb 27, 2023
Step 2
Referred
Mar 10, 2023
E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Provisions · 2 sectionsIntroduced in House
Timeline · 6 actions
May 16, 2024
Subcommittee Consideration and Mark-up Session Held
May 16, 2024
Forwarded by Subcommittee to Full Committee by Voice Vote.
Mar 10, 2023
Referred to the Subcommittee on Health.
Feb 27, 2023
Introduced in House
Feb 27, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 27, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.